Credit Suisse Ag Beyond Spring Inc. Transaction History

Credit Suisse Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.13 - $2.66 $13 - $31	12 New	12 $0
Q4 2021 Feb 14, 2022	SELL	$4.02 - $16.84 $45,200 - $189,348	-11,244 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.26 - $31.31 $104,119 - $352,049	11,244 New	11,244 $177,000
Q1 2021 May 14, 2021	SELL	$10.61 - $15.77 $134,471 - $199,868	-12,674 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$10.21 - $17.31 $129,401 - $219,386	12,674 New	12,674 $154,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $66.6M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.